BY KENTRON RESEARCH
FDA has recently cleared the robotic system from XACT Robotics Ltd. for its use during computed tomography (CT) guided percutaneous interventional procedures. It is the first hands-free robotic system that includes image-based planning and navigation with insertion and steering of various instruments to the desired target.
Harel Gadot, Founder, Executive Chairman and President, XACT Robotics said in a recent press release that “Being the first to introduce a hands-free robotic system, we have the potential to provide significant clinical, technical and economic value while democratizing interventional procedures. Our system’s small footprint and high mobility design will enable care providers to treat a broad range of patient care needs in various clinical sites of service. We are committed to redefining the way the entire medical community utilizes robotics, beginning with interventional radiologists,”
XACT Robotics’ technology can be used with a broad range of imaging devices, can be used on a wide range of clinical application and indications with unprecedented Accuracy, Consistency and Efficiency (ACE).
XACT Robotics has already received CE mark for the robotic system in 2018. It was approved for the CT-guided percutaneous procedures in the abdomen.